Clinical trial for Hip Fractures
Official title A Study to Improve the Collaboration Between Primary and Secondary Health Care on the Treatment of Osteoporosis After a Hip Fracture.
ClinicalTrials.gov ID: NCT05904353
What this study is testing
- What it's testing
- The study wants to find out whether a new system where hospital nurses support the GP improves the chance that patients receive their yearly zoledronic acid infusion after a hip fracture.
- Who it's for
- People aged 75 or older who have had a femoral neck (hip) fracture.
- What's involved
- Participants get the first zoledronic acid infusion in the hospital, then an ambulant nurse helps the GP give yearly infusions for up to three years. They also fill out a questionnaire after one year.
- Time commitment
- The study follows participants for at least one year, with annual infusion visits and a questionnaire at the one‑year mark.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 75 and older
You may be able to join if
- Patients 75 years or older with a hip fracture
You likely can't join if
- Refuse treatment
- Another treatment of osteoporosis is indicated
- Guest patient, do not live in the admission area
- Dementia
The study team makes the final eligibility decision.
Where it is enrolling
- Lørenskog, Akershus, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 75 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Lørenskog, Akershus, Norway. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.